Reviewed,
UniProtKB/Swiss-Prot Q9Y265 (RUVB1_HUMAN)
Last modified
February 9, 2010.
Version 104.
History...
Clusters with 100%,
90%,
50% identity |
Documents (4) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: RuvB-like 1 EC=3.6.1.- Alternative name(s): 49 kDa TATA box-binding protein-interacting protein Short name=49 kDa TBP-interacting protein TIP49a Pontin 52 Nuclear matrix protein 238 Short name=NMP 238 54 kDa erythrocyte cytosolic protein Short name=ECP-54 TIP60-associated protein 54-alpha Short name=TAP54-alpha INO80 complex subunit H | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 456 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Possesses single-stranded DNA-stimulated ATPase and ATP-dependent DNA helicase (3' to 5') activity. Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. RUVBL1 plays an essential role in oncogenic transformation by MYC and also modulates transcriptional activation by the LEF1/TCF1-CTNNB1 complex. Ref.6 Ref.18 Ref.20 Ref.22 Ref.23 May be able to bind plasminogen at cell surface and enhance plasminogen activation. Ref.6 Ref.18 Ref.20 Ref.22 Ref.23 Essential for cell proliferation. Ref.6 Ref.18 Ref.20 Ref.22 Ref.23 |
| Subunit structure | Forms homotypic and heterotypic interactions. Forms a multimeric complex with RUVBL2. Interacts with the transcriptional activation domain of MYC. Component of the RNA polymerase II holoenzyme complex. May also act to bridge the LEF1/TCF1-CTNNB1 complex and TBP. Component of the NuA4 histone acetyltransferase complex which contains the catalytic subunit KAT5/TIP60 and the subunits EP400, TRRAP/PAF400, BRD8/SMAP, EPC1, DMAP1/DNMAP1, RUVBL1/TIP49, RUVBL2, ING3, actin, ACTL6A/BAF53A, MORF4L1/MRG15, MORF4L2/MRGX, MRGBP, YEATS4/GAS41, VPS72/YL1 and MEAF6. The NuA4 complex interacts with MYC and the adenovirus E1A protein. RUVBL1 interacts with EP400. Component of a NuA4-related complex which contains EP400, TRRAP/PAF400, SRCAP, BRD8/SMAP, EPC1, DMAP1/DNMAP1, RUVBL1/TIP49, RUVBL2, actin, ACTL6A/BAF53A, VPS72 and YEATS4/GAS41. Component of the BAF53 complex, at least composed of ACTL6A/BAF53A, RUVBL1/TIP49, SMARCA2/BRM, and TRRAP/PAF400. Component of some MLL1/MLL complex, at least composed of the core components MLL, ASH2L, HCFC1/HCF1, WDR5 and RBBP5, as well as the facultative components C17orf49, CHD8, E2F6, HSP70, IN80C, KIAA1267, LAS1L, MAX, MCRS1, MGA, MYST1/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10. Associates with alpha and gamma tubulins, particularly during metaphase and early anaphase. Interacts with NPAT. Component of the chromatin-remodeling INO80 complex, at least composed of ACTL6A, ACTR5, ACTR8, RVBL1, RVBL2, INO80, INO80B, INO80C, INO80D and INO80E. Interacts with IGHMBP2. Ref.18 Ref.15 Ref.19 Ref.26 Ref.28 |
| Subcellular location | Nucleus matrix. Nucleus › nucleoplasm. Cytoplasm. Membrane. Cytoplasm › cytoskeleton › centrosome. Note: Mainly localized in the nucleus, associated with nuclear matrix or in the nuclear cytosol, although it is also present in the cytoplasm and associated with the cell membranes. In prophase and prometaphase it is located at the centrosome and the branching microtubule spindles. After mitotic nuclear membrane disintigration it accumulates at the centrosome and sites of tubulin polymerization. As cells pass through metaphase and into telophase it is located close to the centrosome at the early phase of tubulin polymerization. In anaphase it accumulates at the zone of tubule interdigitation. In telophase it is found at polar tubule overlap, and it reappears at the site of chromosomal decondensation in the daughter cells. Ref.18 |
| Tissue specificity | Ubiquitously expressed with high expression in heart, skeletal muscle and testis. |
| Domain | Binding to MYC is dependent on a Myc domain essential for oncogenic activity. |
| Miscellaneous | High level of autoantibodies against RUVBL1 are detected in sera of patients with autoimmune diseases such as polymyositis/dermatomyosistis and autoimmune hepatitis. |
| Sequence similarities | Belongs to the ruvB family. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| C2orf44 | Q9H6R7 | 1 | EBI-353675,EBI-346906 | |
| DKC1 | O60832 | 2 | EBI-353675,EBI-713091 | |
| DNASE2 | O00115 | 1 | EBI-353675,EBI-1051412 | |
| DPCD | Q9BVM2 | 1 | EBI-353675,EBI-749988 | |
| E2F7 | Q96AV8 | 1 | EBI-353675,EBI-1386765 | |
| FDFT1 | P37268 | 1 | EBI-353675,EBI-714550 | |
| GNAS | P63092 | 1 | EBI-353675,EBI-1047114 | |
| HLA-B | P30480 | 1 | EBI-353675,EBI-1054175 | |
| PELO | Q9BRX2 | 1 | EBI-353675,EBI-1043580 | |
| PSTPIP1 | O43586 | 1 | EBI-353675,EBI-1050964 | |
| RUVBL2 | Q9Y230 | 4 | EBI-353675,EBI-352939 | |
| SMNDC1 | O75940 | 1 | EBI-353675,EBI-1052641 | |
| TERT | O14746 | 2 | EBI-353675,EBI-1772203 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9Y265-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9Y265-2) The sequence of this isoform differs from the canonical sequence as follows: 374-386: IIKIRAQTEGINI → VLSAAADPGQLAC 387-456: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 456 | 456 | RuvB-like 1 | PRO_0000165639 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 70 – 77 | 8 | ATP By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 2 | 1 | N6-acetyllysine Ref.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 453 | 1 | N6-acetyllysine Ref.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 374 – 386 | 13 | IIKIR…EGINI → VLSAAADPGQLAC in isoform 2. | VSP_021387 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 387 – 456 | 70 | Missing in isoform 2. | VSP_021388 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 302 | 1 | D → N: Inhibition of MYC- and CTNNB1-mediated transformation. Ref.22 Ref.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 52 | 1 | I → T in BAD96283. Ref.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 145 | 1 | N → D in BAD96295. Ref.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 285 | 1 | K → R in ABF13334. Ref.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 353 | 1 | D → P in ABF13334. Ref.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 10 – 16 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 17 – 20 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 43 – 48 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 52 – 57 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 65 – 69 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 77 – 86 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 94 – 96 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 104 – 106 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 108 – 118 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 123 – 131 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 157 – 159 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 170 – 172 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 174 – 182 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 191 – 195 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 200 – 202 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 216 – 221 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 229 – 237 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 240 – 245 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 279 – 288 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 299 – 301 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 304 – 306 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 309 – 318 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 327 – 330 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 352 – 355 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 358 – 362 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 368 – 381 | 14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 388 – 393 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 403 – 408 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 410 – 419 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 427 – 436 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 440 – 448 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "TIP49, homologous to the bacterial DNA helicase RuvB, acts as an autoantigen in human." Makino Y., Mimori T., Koike C., Kanemaki M., Kurokawa Y., Inoue S., Kishimoto T., Tamura T.-A. Biochem. Biophys. Res. Commun. 245:819-823(1998) [PubMed: 9588198] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Liver. |
| [2] | "Identification and characterization of the ubiquitously occurring nuclear matrix protein NMP 238." Holzmann K., Gerner C., Korosec T., Poeltl A., Grimm R., Sauermann G. Biochem. Biophys. Res. Commun. 252:39-45(1998) [PubMed: 9813143] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 1-7. Tissue: Pancreas. |
| [3] | "An eukaryotic RuvB-like protein (RUVBL1) essential for growth." Qiu X.-B., Lin Y.-L., Thome K.C., Pian P., Schlegel B.P., Weremowicz S., Parvin J.D., Dutta A. J. Biol. Chem. 273:27786-27793(1998) [PubMed: 9774387] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Placenta. |
| [4] | "Pontin52, an interaction partner of beta-catenin, binds to the TATA box binding protein." Bauer A., Huber O., Kemler R. Proc. Natl. Acad. Sci. U.S.A. 95:14787-14792(1998) [PubMed: 9843967] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Colon adenocarcinoma. |
| [5] | "Isolation, molecular characterization, and tissue-specific expression of ECP-51 and ECP-54 (TIP49), two homologous, interacting erythroid cytosolic proteins." Salzer U., Kubicek M., Prohaska R. Biochim. Biophys. Acta 1446:365-370(1999) [PubMed: 10524211] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 34-46; 108-118; 169-177; 207-219 AND 446-456. Tissue: Bone marrow. |
| [6] | "Purification, cloning, and characterization of a profibrinolytic plasminogen-binding protein, TIP49a." Hawley S.B., Tamura T.-A., Miles L.A. J. Biol. Chem. 276:179-186(2001) [PubMed: 11027681] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 172-182 AND 184-201, FUNCTION. |
| [7] | "The genomic structure of the human pontin 52 gene." Huber O., Orso S. Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1). |
| [8] | "RUVBL1-FK- splice variant." Koc F., Gartner W., Birkenkamp-Demtroeder K., Altenberger T., Daneva T., Wagner L. Submitted (MAR-2006) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). |
| [9] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [10] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Cerebellum. |
| [11] | Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Adipose tissue and Coronary artery. |
| [12] | "Human protein factory for converting the transcriptome into an in vitro-expressed proteome." Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R., Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y., Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B. Nomura N.Nat. Methods 5:1011-1017(2008) [PubMed: 19054851] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [13] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Lung. |
| [14] | Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y. Submitted (DEC-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 23-33; 65-90; 153-162; 172-182; 318-333; 340-357; 363-372 AND 379-400, MASS SPECTROMETRY. Tissue: Brain, Cajal-Retzius cell and Fetal brain cortex. |
| [15] | "An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc." Wood M.A., McMahon S.B., Cole M.D. Mol. Cell 5:321-330(2000) [PubMed: 10882073] [Abstract] Cited for: PROTEIN SEQUENCE OF 23-33 AND 77-90, INTERACTION WITH MYC, MUTAGENESIS OF ASP-302. |
| [16] | "Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-containing histone acetyltransferase complex." Cai Y., Jin J., Tomomori-Sato C., Sato S., Sorokina I., Parmely T.J., Conaway R.C., Conaway J.W. J. Biol. Chem. 278:42733-42736(2003) [PubMed: 12963728] [Abstract] Cited for: PROTEIN SEQUENCE OF 23-33; 34-46; 77-90; 172-182; 185-201; 340-357 AND 405-418 (ISOFORM 1), IDENTIFICATION IN NUA4 COMPLEX, MASS SPECTROMETRY. |
| [17] | "Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis." Ikura T., Ogryzko V.V., Grigoriev M., Groisman R., Wang J., Horikoshi M., Scully R., Qin J., Nakatani Y. Cell 102:463-473(2000) [PubMed: 10966108] [Abstract] Cited for: PROTEIN SEQUENCE OF 34-46 AND 108-117, IDENTIFICATION IN NUA4 COMPLEX, MASS SPECTROMETRY. |
| [18] | "The ATP-dependent helicase RUVBL1/TIP49a associates with tubulin during mitosis." Gartner W., Rossbacher J., Zierhut B., Daneva T., Base W., Weissel M., Waldhausl W., Pasternack M.S., Wagner L. Cell Motil. Cytoskeleton 56:79-93(2003) [PubMed: 14506706] [Abstract] Cited for: PROTEIN SEQUENCE OF 34-46, FUNCTION, INTERACTION WITH TUBULIN, SUBCELLULAR LOCATION. Tissue: Monocyte. |
| [19] | "TIP49b, a new RuvB-like DNA helicase, is included in a complex together with another RuvB-like DNA helicase, TIP49a." Kanemaki M., Kurokawa Y., Matsu-ura T., Makino Y., Masani A., Okazaki K., Morishita T., Tamura T.-A. J. Biol. Chem. 274:22437-22444(1999) [PubMed: 10428817] [Abstract] Cited for: INTERACTION WITH RUVBL2. |
| [20] | "Pontin52 and reptin52 function as antagonistic regulators of beta-catenin signalling activity." Bauer A., Chauvet S., Huber O., Usseglio F., Rothbaecher U., Aragnol D., Kemler R., Pradel J. EMBO J. 19:6121-6130(2000) [PubMed: 11080158] [Abstract] Cited for: FUNCTION. |
| [21] | "BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation." Park J., Wood M.A., Cole M.D. Mol. Cell. Biol. 22:1307-1316(2002) [PubMed: 11839798] [Abstract] Cited for: IDENTIFICATION IN BAF53 COMPLEX WITH ACTL6A; SMARCA2 AND TRRAP. |
| [22] | "TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling." Feng Y., Lee N., Fearon E.R. Cancer Res. 63:8726-8734(2003) [PubMed: 14695187] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF ASP-302. |
| [23] | "Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans." Doyon Y., Selleck W., Lane W.S., Tan S., Cote J. Mol. Cell. Biol. 24:1884-1896(2004) [PubMed: 14966270] [Abstract] Cited for: FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN NUA4 COMPLEX, IDENTIFICATION IN A NUA4-RELATED SRCAP-CONTAINING COMPLEX. |
| [24] | "Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF." Dou Y., Milne T.A., Tackett A.J., Smith E.R., Fukuda A., Wysocka J., Allis C.D., Chait B.T., Hess J.L., Roeder R.G. Cell 121:873-885(2005) [PubMed: 15960975] [Abstract] Cited for: IDENTIFICATION IN THE MLL1/MLL COMPLEX. |
| [25] | "A mammalian chromatin remodeling complex with similarities to the yeast INO80 complex." Jin J., Cai Y., Yao T., Gottschalk A.J., Florens L., Swanson S.K., Gutierrez J.L., Coleman M.K., Workman J.L., Mushegian A., Washburn M.P., Conaway R.C., Conaway J.W. J. Biol. Chem. 280:41207-41212(2005) [PubMed: 16230350] [Abstract] Cited for: IDENTIFICATION IN INO80 COMPLEX, IDENTIFICATION BY MASS SPECTROMETRY. |
| [26] | "Transcriptional activation of histone genes requires NPAT-dependent recruitment of TRRAP-Tip60 complex to histone promoters during the G1/S phase transition." DeRan M., Pulvino M., Greene E., Su C., Zhao J. Mol. Cell. Biol. 28:435-447(2008) [PubMed: 17967892] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH NPAT. |
| [27] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [28] | "Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery." de Planell-Saguer M., Schroeder D.G., Rodicio M.C., Cox G.A., Mourelatos Z. Hum. Mol. Genet. 18:2115-2126(2009) [PubMed: 19299493] [Abstract] Cited for: INTERACTION WITH IGHMBP2. |
| [29] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed: 19608861] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-2 AND LYS-453, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AB012122 mRNA. Translation: BAA28169.1. AJ010058 mRNA. Translation: CAA08986.1. AF070735 mRNA. Translation: AAC77819.1. AF099084 mRNA. Translation: AAD04427.1. Y18418 mRNA. Translation: CAB46271.1. AF380344, AF380343 Genomic DNA. Translation: AAM45570.1. DQ469310 mRNA. Translation: ABF13334.1. BT007057 mRNA. Translation: AAP35706.1. AK222563 mRNA. Translation: BAD96283.1. AK222575 mRNA. Translation: BAD96295.1. AK312290 mRNA. Translation: BAG35217.1. AB451224 mRNA. Translation: BAG70038.1. BC002993 mRNA. Translation: AAH02993.1. BC012886 mRNA. Translation: AAH12886.1. | ||||||||||||
| IPI | IPI00021187. IPI00788942. | ||||||||||||
| PIR | JE0334. | ||||||||||||
| RefSeq | NP_003698.1. | ||||||||||||
| UniGene | Hs.272822 | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-29937N. | ||||||||||||
| IntAct | Q9Y265. 69 interactions. | ||||||||||||
| STRING | Q9Y265. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q9Y265. | ||||||||||||
2-D gel databases | |||||||||||||
| SWISS-2DPAGE | Q9Y265. | ||||||||||||
| OGP | Q9Y265. | ||||||||||||
| REPRODUCTION-2DPAGE | Q9Y265. | ||||||||||||
Proteomic databases | |||||||||||||
| PeptideAtlas | Q9Y265. | ||||||||||||
| PRIDE | Q9Y265. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000322623; ENSP00000318297; ENSG00000175792; Homo sapiens. [Genome view] | ||||||||||||
| GeneID | 8607. | ||||||||||||
| KEGG | hsa:8607. | ||||||||||||
| UCSC | uc003ekf.1. human. uc003ekh.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 8607. | ||||||||||||
| GeneCards | GC03M129282. | ||||||||||||
| H-InvDB | HIX0021235. | ||||||||||||
| HGNC | HGNC:10474. RUVBL1. | ||||||||||||
| HPA | HPA019947. HPA019948. | ||||||||||||
| MIM | 603449. gene. | ||||||||||||
| PharmGKB | PA34887. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | prNOG09539. | ||||||||||||
| HOVERGEN | Q9Y265. | ||||||||||||
| InParanoid | Q9Y265. | ||||||||||||
| OMA | KRVGRSD. | ||||||||||||
| OrthoDB | EOG9F4VW7. | ||||||||||||
| PhylomeDB | Q9Y265. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q9Y265. | ||||||||||||
| Bgee | Q9Y265. | ||||||||||||
| CleanEx | HS_RUVBL1. | ||||||||||||
| Genevestigator | Q9Y265. | ||||||||||||
| GermOnline | ENSG00000175792. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR003593. ATPase_AAA+_core. IPR010339. TIP49_C. [Graphical view] | ||||||||||||
| Pfam | PF06068. TIP49. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00382. AAA. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| NextBio | 32249. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | RUVB1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9Y265 Secondary accession number(s): B2R5S0 Q9BSX9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 3 Human chromosome 3: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


